Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13244 | 786 | 41.7 | 84% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MELANIN CONCENTRATING HORMONE | Author keyword | 191 | 63% | 24% | 190 |
2 | MELANIN CONCENTRATING HORMONE MCH | Author keyword | 82 | 85% | 6% | 44 |
3 | MCH | Author keyword | 77 | 56% | 12% | 95 |
4 | MCHR1 | Author keyword | 69 | 96% | 3% | 22 |
5 | MCH R1 ANTAGONISTS | Author keyword | 61 | 95% | 3% | 20 |
6 | MCH R1 | Author keyword | 30 | 100% | 2% | 12 |
7 | MCH RECEPTOR | Author keyword | 30 | 100% | 2% | 12 |
8 | MELANIN CONCENTRATING HORMONE RECEPTOR | Author keyword | 26 | 87% | 2% | 13 |
9 | MCH R1 ANTAGONIST | Author keyword | 14 | 100% | 1% | 7 |
10 | MCH1 | Author keyword | 12 | 86% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MELANIN CONCENTRATING HORMONE | 191 | 63% | 24% | 190 | Search MELANIN+CONCENTRATING+HORMONE | Search MELANIN+CONCENTRATING+HORMONE |
2 | MELANIN CONCENTRATING HORMONE MCH | 82 | 85% | 6% | 44 | Search MELANIN+CONCENTRATING+HORMONE+MCH | Search MELANIN+CONCENTRATING+HORMONE+MCH |
3 | MCH | 77 | 56% | 12% | 95 | Search MCH | Search MCH |
4 | MCHR1 | 69 | 96% | 3% | 22 | Search MCHR1 | Search MCHR1 |
5 | MCH R1 ANTAGONISTS | 61 | 95% | 3% | 20 | Search MCH+R1+ANTAGONISTS | Search MCH+R1+ANTAGONISTS |
6 | MCH R1 | 30 | 100% | 2% | 12 | Search MCH+R1 | Search MCH+R1 |
7 | MCH RECEPTOR | 30 | 100% | 2% | 12 | Search MCH+RECEPTOR | Search MCH+RECEPTOR |
8 | MELANIN CONCENTRATING HORMONE RECEPTOR | 26 | 87% | 2% | 13 | Search MELANIN+CONCENTRATING+HORMONE+RECEPTOR | Search MELANIN+CONCENTRATING+HORMONE+RECEPTOR |
9 | MCH R1 ANTAGONIST | 14 | 100% | 1% | 7 | Search MCH+R1+ANTAGONIST | Search MCH+R1+ANTAGONIST |
10 | MCH1 | 12 | 86% | 1% | 6 | Search MCH1 | Search MCH1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SLC 1 | 257 | 98% | 8% | 62 |
2 | MCH RECEPTOR | 114 | 95% | 5% | 38 |
3 | HORMONE RECEPTOR 1 ANTAGONISTS | 110 | 95% | 5% | 37 |
4 | MCH | 101 | 81% | 8% | 62 |
5 | MCHR1 ANTAGONISTS | 65 | 95% | 3% | 21 |
6 | NEUROPEPTIDE E I | 59 | 90% | 3% | 26 |
7 | 2 AMINO 8 ALKOXY QUINOLINES | 48 | 100% | 2% | 17 |
8 | HUMAN MCH RECEPTOR | 45 | 94% | 2% | 16 |
9 | PUTATIVE NEUROPEPTIDES | 38 | 93% | 2% | 14 |
10 | ANTIOBESITY AGENTS | 35 | 74% | 3% | 26 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Expanding the scales: The multiple roles of MCH in regulating energy balance and other biological functions | 2006 | 104 | 141 | 82% |
Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists | 2011 | 14 | 40 | 95% |
MCH-R1 antagonists: what is keeping most research programs away from the clinic? | 2007 | 42 | 52 | 88% |
Anatomical organization of the melanin-concentrating hormone peptide family in the mammalian brain | 2011 | 28 | 110 | 53% |
Anti-obesity effects of small molecule melanin-concentrating hormone receptor1 (MCHR1) antagonists | 2007 | 40 | 102 | 85% |
Melanin-concentrating hormone control of sleep-wake behavior | 2013 | 11 | 48 | 58% |
Discovery and development of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity | 2007 | 20 | 95 | 94% |
Animals models of MCH function and what they can tell us about its role in energy balance | 2009 | 16 | 60 | 93% |
From preclinical to clinical development: The example of a novel treatment for obesity | 2014 | 2 | 10 | 60% |
Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for obesity the treatment of obesity | 2004 | 56 | 66 | 76% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHEM NEUROANAT | 6 | 35% | 1.8% | 14 |
2 | PEPTIDES CHIM COMBINATOIRE | 3 | 100% | 0.4% | 3 |
3 | CATEDRA BACTERIOL VIROL MED | 3 | 50% | 0.5% | 4 |
4 | CVGI BIOSCI | 3 | 50% | 0.5% | 4 |
5 | TARGET DISCOVERY ASSESSMENT | 3 | 60% | 0.4% | 3 |
6 | EA3922 | 2 | 33% | 0.8% | 6 |
7 | ZLF | 2 | 20% | 1.0% | 8 |
8 | CHIM COMBINATOIRE CHIM PEPTIDES | 1 | 100% | 0.3% | 2 |
9 | CONSEJO NACL INVEST CIENT TECN IMBECU CONICET | 1 | 100% | 0.3% | 2 |
10 | NEUROSCI ENDOCRINE DISCOVERY | 1 | 50% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000139553 | OREXIN//OREXIN A//HYPOCRETIN |
2 | 0.0000113109 | MELANOPHORES//MELANOPHORE//PIGMENT TRANSLOCATION |
3 | 0.0000090762 | CART PEPTIDE//COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT//CART |
4 | 0.0000075076 | PROOPIOMELANOCORTIN//PROOPIOCORTIN//PROOPIOMELANOTROPIN |
5 | 0.0000072168 | MELANOCORTIN//MELANOCORTIN 4 RECEPTOR//MELANOCORTIN RECEPTOR |
6 | 0.0000045386 | HYPOTHALAM//A2 NORADRENERGIC NEURONS//LASER CATAPULT MICRODISSECTION |
7 | 0.0000031059 | NEUROMEDIN U//NEUROPEPTIDE W//NEUROMEDIN S |
8 | 0.0000030838 | MELANOMA IMAGING//IMAGERIE MOL THER IE VECTORISEE//MELANOMA TARGETING |
9 | 0.0000029498 | NESFATIN 1//NUCB2//NUCLEOBINDIN 2 |
10 | 0.0000029071 | CHROMOSOME 6Q DELETION//SIM1 GENE//6Q DELETION |